[{"address1": "3963 Maple Avenue", "address2": "Suite 350", "city": "Dallas", "state": "TX", "zip": "75219", "country": "United States", "phone": "972 499 3350", "website": "https://instilbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.", "fullTimeEmployees": 49, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bronson  Crouch", "age": 51, "title": "Chairman & CEO", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 1140189, "exercisedValue": 0, "unexercisedValue": 35349}, {"maxAge": 1, "name": "Dr. Sandeep  Laumas M.D.", "age": 55, "title": "CFO & Chief Business Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 741521, "exercisedValue": 0, "unexercisedValue": 61910}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 19.32, "open": 19.06, "dayLow": 19.06, "dayHigh": 20.3, "regularMarketPreviousClose": 19.32, "regularMarketOpen": 19.06, "regularMarketDayLow": 19.06, "regularMarketDayHigh": 20.3, "payoutRatio": 0.0, "beta": 1.724, "forwardPE": -1.665286, "volume": 77822, "regularMarketVolume": 77822, "averageVolume": 96313, "averageVolume10days": 98180, "averageDailyVolume10Day": 98180, "bid": 19.78, "ask": 20.57, "bidSize": 1, "askSize": 1, "marketCap": 131170392, "fiftyTwoWeekLow": 9.62, "fiftyTwoWeekHigh": 92.0, "fiftyDayAverage": 21.6195, "twoHundredDayAverage": 23.28135, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 95372328, "profitMargins": 0.0, "floatShares": 2670001, "sharesOutstanding": 6525890, "sharesShort": 499941, "sharesShortPriorMonth": 669087, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0766, "heldPercentInsiders": 0.1282, "heldPercentInstitutions": 0.80386, "shortRatio": 6.32, "shortPercentOfFloat": 0.13260001, "impliedSharesOutstanding": 6525890, "bookValue": 27.023, "priceToBook": 0.74381083, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -75165000, "trailingEps": -11.56, "forwardEps": -12.07, "lastSplitFactor": "1:20", "lastSplitDate": 1701993600, "enterpriseToEbitda": -1.676, "52WeekChange": 0.56058156, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 20.1, "targetHighPrice": 180.0, "targetLowPrice": 52.0, "targetMeanPrice": 114.0, "targetMedianPrice": 110.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 121143000, "totalCashPerShare": 18.563, "ebitda": -56910000, "totalDebt": 85345000, "quickRatio": 11.784, "currentRatio": 12.896, "debtToEquity": 48.4, "returnOnAssets": -0.12404, "returnOnEquity": -0.36633998, "freeCashflow": -24233376, "operatingCashflow": -58518000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1740777656, "regularMarketTime": 1740776401, "exchange": "NCM", "messageBoardId": "finmb_638929728", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Instil Bio, Inc.", "longName": "Instil Bio, Inc.", "regularMarketChangePercent": 4.0372705, "regularMarketPrice": 20.1, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616160600000, "postMarketChangePercent": -4.36468, "postMarketPrice": 19.2227, "postMarketChange": -0.8773, "regularMarketChange": 0.7800007, "regularMarketDayRange": "19.06 - 20.3", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 96313, "fiftyTwoWeekLowChange": 10.4800005, "fiftyTwoWeekLowChangePercent": 1.0893972, "fiftyTwoWeekRange": "9.62 - 92.0", "fiftyTwoWeekHighChange": -71.9, "fiftyTwoWeekHighChangePercent": -0.78152174, "fiftyTwoWeekChangePercent": 56.058155, "earningsTimestampStart": 1742381940, "earningsTimestampEnd": 1742817600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -11.56, "epsForward": -12.07, "epsCurrentYear": -12.27, "priceEpsCurrentYear": -1.6381418, "fiftyDayAverageChange": -1.5194988, "fiftyDayAverageChangePercent": -0.07028372, "twoHundredDayAverageChange": -3.1813488, "twoHundredDayAverageChangePercent": -0.13664795, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "cryptoTradeable": false, "displayName": "Instil Bio", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]